Milad Bastami

Dr. Milad Bastami

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
PGPourya Gholizadeh
Pourya Gholizadeh
MMMajid Mahallei
Majid Mahallei
APAli Pormohammad
Ali Pormohammad
MVMojtaba Varshochi
Mojtaba Varshochi
KGKhudaverdi Ganbarov
Khudaverdi Ganbarov
Hossein Samadi KafilHossein Samadi Kafil
Hossein Samadi Kafil

14 November 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
MAMaryam Abolghasemi
Maryam Abolghasemi
STSadra Samavarchi Tehrani
Sadra Samavarchi Tehrani
TYTooba Yousefi
Tooba Yousefi
AKAnsar Karimian
Ansar Karimian
AMAta Mahmoodpoor
Ata Mahmoodpoor
VRVahid Rameshknia
Vahid Rameshknia

7 September 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MZMaryam Zare
Maryam Zare
Milad BastamiMilad Bastami
Milad Bastami
SSSaeed Solali
Saeed Solali
MAMohammad Reza Alivand
Mohammad Reza Alivand

1 April 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Mahdi RahimiMahdi Rahimi
Mahdi Rahimi
RKRamin Karimian
Ramin Karimian
ENEhsan Bahojb Noruzi
Ehsan Bahojb Noruzi
KGKhudaverdi Ganbarov
Khudaverdi Ganbarov
MZMojtaba Zarei
Mojtaba Zarei
Hossein Samadi KafilHossein Samadi Kafil
Hossein Samadi Kafil
Background: Chemotherapy as an important tool for cancer treatment faces many obstacles such as multidrug resistance and adverse toxic effects on healthy tissues. Drug delivery systems has opened a new window to overcome these problems. There has been a strong interest development of new platform and system for delivof chemotherapeutic agents. Purpose: In the present study, a green synthesis method was chosen and performed for preparation of a novel amphoteric calix[4]arene (Calix) macrocycle with low toxicity to the human body. Materials and methods: The amphoteric Calix was coated on the surface of Fe3O4 magnetic nanoparticles and used as a magnetic nanocarrier for simultaneous delivery of two anticancer agents, doxorubicin and methotrexate, against MCF7 cancer cells. Several chemical characterizations were done for validation of prepared nanocarrier, and in vitro loading and release studies of drugs were performed with good encapsulation efficiency. Results: In vitro biological studies including hemolysis assay, erythrocytes sedimentation rate, red blood cells aggregation, cyto cellular internalization, and apoptosis evaluations were performed. Based on results, the developed nanocarrier has many advantages and capability for an efficient codelivery of DOX and MTX, which has a highly potent ability to kill cancer cells. Conclusion: All these results persuade us, this nanocarrier could be effectively used for cancer therapy of MCF7 breast cancer cells and is suitable for use in further animal studies in future investigations.

15 June 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MAMaryam Abtin
Maryam Abtin
MAMohammad R. Alivand
Mohammad R. Alivand
MKMahmoud S. Khaniani
Mahmoud S. Khaniani
Milad BastamiMilad Bastami
Milad Bastami
MZMohammad Zaeifizadeh
Mohammad Zaeifizadeh
SDSima M. Derakhshan
Sima M. Derakhshan

17 January 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
MAMaryam Abolghasemi
Maryam Abolghasemi
STSadra S. Tehrani
Sadra S. Tehrani
TYTooba Yousefi
Tooba Yousefi
AKAnsar Karimian
Ansar Karimian
AMAta Mahmoodpoor
Ata Mahmoodpoor
VRVahid Rameshknia
Vahid Rameshknia